<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2025-11-29 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2025-11-29/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2025-11-29"><meta property="og:description" content="ğŸ“… Daily Report - 2025-11-29 ä»Šæ—¥ç­›é€‰å‡º 88 æ¡å†…å®¹ï¼Œæ¥è‡ª 4 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2025-11-29T00:00:00+00:00"><meta property="article:modified_time" content="2025-11-29T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week482025"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2025-11-29"><meta itemprop=description content="ğŸ“… Daily Report - 2025-11-29 ä»Šæ—¥ç­›é€‰å‡º 88 æ¡å†…å®¹ï¼Œæ¥è‡ª 4 ä¸ªæ¥æº"><meta itemprop=datePublished content="2025-11-29T00:00:00+00:00"><meta itemprop=dateModified content="2025-11-29T00:00:00+00:00"><meta itemprop=wordCount content="2424"><meta itemprop=keywords content="Research,Daily,Week482025"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2025-11-29"><meta name=twitter:description content="ğŸ“… Daily Report - 2025-11-29 ä»Šæ—¥ç­›é€‰å‡º 88 æ¡å†…å®¹ï¼Œæ¥è‡ª 4 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-29</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2025-11-29T00:00:00Z>2025-11-29</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</a></li><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2025-11-29>ğŸ“… Daily Report - 2025-11-29</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>88</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>4</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
é¦–æ¬¡ç³»ç»Ÿæ­ç¤ºä¸‰çº§æ·‹å·´ç»“æ„åœ¨èƒƒç™Œå…ç–«å¾®ç¯å¢ƒä¸­çš„å…³é”®ä½œç”¨ï¼Œå¹¶å¼€å‘åˆ›æ–°å·¥å…·é¢„æµ‹å…ç–«æ²»ç–—ååº”ã€‚Natureå‘ç°PD-1ä¸ä»…æŠ‘åˆ¶Tç»†èƒæŠ—ç™Œæ´»æ€§ï¼Œè¿˜ä¿æŠ¤å…¶å…äºè€—ç«­ï¼Œæç¤ºå…ç–«æ²»ç–—éœ€å¹³è¡¡ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒè°ƒæ§</strong>ï¼šè¯†åˆ«HLA-DR+è‚¿ç˜¤ç»†èƒã€MARCO+å·¨å™¬ç»†èƒã€PLAUR+ä¸­æ€§ç²’ç»†èƒã€è¡°è€CD8+Tç»†èƒã€æˆçº¤ç»´ç»†èƒï¼ˆMMP11+ï¼‰ç­‰å…³é”®ç»†èƒç±»å‹åŠå…¶å¯¹å…ç–«æ²»ç–—çš„å½±å“ï¼Œå¹¶æ¢ç´¢é˜»æ–­MARCOã€PLAURæˆ–è°ƒæ§è¡°è€ç»†èƒçš„ç­–ç•¥ã€‚</li><li><strong>ä»£è°¢ä¸å…ç–«</strong>ï¼šå·¨å™¬ç»†èƒèƒè‘¬é©±åŠ¨å¤šèƒºä»£è°¢å¢å¼ºç™Œå¹²ç»†èƒå¯Œé›†åŠè€è¯ï¼›è°ƒæ§ä»£è°¢é€”å¾„ï¼ˆå¦‚ä¹™é†‡é…¸ä»£è°¢ï¼‰ä»¥è°ƒåŠ¨å›ºæœ‰å…ç–«åŠ›æŠ—è‚¿ç˜¤ã€‚</li><li><strong>è‚¿ç˜¤ç»†èƒä¸å®¿ä¸»äº’ä½œ</strong>ï¼šæ­ç¤ºç¥ç»å…ƒ-ç™Œç»†èƒå‡æ€§çªè§¦å¢å¼ºèƒ°è…ºç™Œç¥ç»æµ¸æ¶¦ï¼›DMFé‡Šæ”¾mtDNAæ¿€æ´»cGAS-STINGé€šè·¯å¢å¼ºæŠ—è‚¿ç˜¤å…ç–«ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>å¤šç»„å­¦æ•´åˆåˆ†æ</strong>ï¼šå•ç»†èƒRNAæµ‹åºã€ç©ºé—´è½¬å½•ç»„å­¦ã€ä½“ç»†èƒè¡¨çªå˜å…‹éš†è¿½è¸ªç­‰æŠ€æœ¯åœ¨è‚¿ç˜¤å…ç–«ã€è¡°è€ã€ç–¾ç—…æœºåˆ¶ç ”ç©¶ä¸­çš„å¹¿æ³›åº”ç”¨ã€‚</li><li><strong>ç”Ÿç‰©ä¿¡æ¯å­¦å·¥å…·å¼€å‘</strong>ï¼šå¼€å‘é¢„æµ‹å…ç–«æ²»ç–—ååº”çš„æ–°å·¥å…·ï¼›Kraken2å®ç°å¿«é€Ÿå¾®ç”Ÿç‰©ç»„åˆ†ç±»ã€‚</li></ul><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
MHC II-restricted neoantigenç–«è‹—æœ‰æ•ˆé€†è½¬å†·è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒï¼Œå…‹æœå…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚è€è¯æ€§ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è‚¿ç˜¤å…ç–«æ²»ç–—ï¼šé€šè¿‡ç–«è‹—æˆ–è¯ç‰©ï¼ˆå¦‚DOT1LæŠ‘åˆ¶å‰‚ï¼‰é‡å¡‘è‚¿ç˜¤å¾®ç¯å¢ƒï¼Œæ¿€æ´»å…ç–«ååº”ã€‚</li><li>ä»£è°¢ä¸å…ç–«ï¼šç ”ç©¶é¤åä»£è°¢å˜åŒ–å¯¹Tç»†èƒå…ç–«çš„æŒä¹…å½±å“ï¼Œä»¥åŠL-è‹¯ä¸™æ°¨é…¸åœ¨Th2ç»†èƒä»£è°¢è°ƒæ§ä¸­çš„ä½œç”¨ã€‚</li><li>ç–¾ç—…æœºåˆ¶ç ”ç©¶ï¼šè§£æNFATc1/c2åœ¨å„¿ç«¥T-ALLç³–çš®è´¨æ¿€ç´ æŠµæŠ—ä¸­çš„ä½œç”¨ï¼›æ¢ç´¢m6Aç”²åŸºåŒ–ã€BRCA1çªå˜ã€C-Cè¶‹åŒ–å› å­å—ä½“4åŸºå› ç¼ºå¤±åŠRIG-Iæ¿€æ´»åœ¨ä¸åŒç–¾ç—…ä¸­çš„ä½œç”¨ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>æ•´åˆå¤šç»„å­¦åˆ†æï¼ˆATAC-seq, RNA-seq, m6Aæµ‹åº, å…¨åŸºå› ç»„æµ‹åºï¼‰æ­ç¤ºåŸºå› è°ƒæ§å’Œè¡¨è§‚é—ä¼ æœºåˆ¶ã€‚</li><li>åˆ©ç”¨æ•°å­—å­ªç”ŸæŠ€æœ¯è¿›è¡Œä½“å†…ä»£è°¢é€šé‡ä¼°ç®—ã€‚</li></ul><h3 id=-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š</p></blockquote><ul><li>æ™šæœŸå®«é¢ˆç™Œä¸€çº¿æ²»ç–—ä¸­ï¼Œé™çº§åŒ–ç–—è”åˆå®‰æ´›æ›¿å°¼å’Œå½­æ™®åˆ©å•æŠ—å±•ç°å‡ºæ²»ç–—æ½œåŠ›ã€‚</li><li>é¦–æ¬¡æ„å»ºçš„CIC::DUX4è‚‰ç˜¤ï¼ˆCDSï¼‰è¯±å¯¼æ¨¡å‹imChCDSï¼Œæ­ç¤ºäº†ç™ŒåŸºå› ä»‹å¯¼çš„MHCIä¾èµ–å…ç–«é€ƒè„±æœºåˆ¶ã€‚</li></ul><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>æ¢ç´¢æ™šæœŸå®«é¢ˆç™Œæ‚£è€…ä¸€çº¿é™çº§åŒ–ç–—è”åˆå®‰æ´›æ›¿å°¼å’Œå½­æ™®åˆ©å•æŠ—çš„ç–—æ•ˆåŠåˆ†å­å…ç–«ç›¸å…³æ€§ã€‚</li><li>æ„å»ºå¹¶éªŒè¯CIC::DUX4è‚‰ç˜¤ï¼ˆCDSï¼‰è¯±å¯¼å°é¼ æ¨¡å‹ï¼Œç ”ç©¶å…¶è‚¿ç˜¤å‘ç”Ÿæœºåˆ¶åŠå…ç–«é€ƒé€¸é€”å¾„ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>å¼€å‘äº†é¦–ä¸ªå¯è¯±å¯¼çš„CIC::DUX4è‚‰ç˜¤ï¼ˆCDSï¼‰å°é¼ æ¨¡å‹ï¼ˆimChCDSï¼‰ï¼Œå¿ å®é‡ç°äº†äººç±»CDSçš„ç‰¹å¾ã€‚</li><li>ç ”ç©¶äº†é™çº§åŒ–ç–—è”åˆå®‰æ´›æ›¿å°¼å’Œå½­æ™®åˆ©å•æŠ—åœ¨PD-L1é˜³æ€§æ™šæœŸå®«é¢ˆç™Œæ‚£è€…ä¸­çš„ä¸€çº¿æ²»ç–—æ•ˆæœã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
ç ”ç©¶å‘ç°ï¼Œé™ä½é¥®ç”¨æ°´ç ·å«é‡å¯æ˜¾è‘—é™ä½ç™Œç—‡å’Œå¿ƒè„ç—…æ­»äº¡ç‡ï¼›æ–°å‹â€œçº³ç±³èŠ±â€è¶…è½½å¹²ç»†èƒï¼Œæœ‰æœ›ä¸ºè¡°è€ç»†èƒâ€œå……ç”µâ€ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>ç¯å¢ƒå¥åº·ï¼šé€šè¿‡æ”¹å–„é¥®ç”¨æ°´è´¨é‡ï¼Œé™ä½æ…¢æ€§ç—…æ­»äº¡ç‡ã€‚</li><li>ç¥ç»é€€è¡Œæ€§ç–¾ç—…ï¼šæ¢ç´¢ä½“å†…å¤©ç„¶åˆ†å­ï¼ˆå¦‚ç²¾èƒºï¼‰åœ¨å¯¹æŠ—é˜¿å°”èŒ¨æµ·é»˜ç—…å’Œå¸•é‡‘æ£®ç—…ä¸­çš„ä½œç”¨ã€‚</li><li>å†ç”ŸåŒ»å­¦ï¼šåˆ©ç”¨çº³ç±³æŠ€æœ¯å¢å¼ºå¹²ç»†èƒåŠŸèƒ½ï¼Œç”¨äºä¿®å¤è¡°è€ç»†èƒã€‚</li><li>ç¯å¢ƒæ¯’ç´ æ¸…é™¤ï¼šå¼€å‘ç”Ÿç‰©å·¥å…·ï¼ˆå¦‚å…‰åˆç»†èŒï¼‰ä»¥åº”å¯¹æŒä¹…æ€§åŒ–å­¦æ±¡æŸ“ç‰©ï¼ˆPFASï¼‰ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>åˆ©ç”¨â€œçº³ç±³èŠ±â€é¢—ç²’æ˜¾è‘—æé«˜å¹²ç»†èƒçº¿ç²’ä½“äº§é‡ï¼Œå®ç°èƒ½é‡è½¬ç§»ã€‚</li><li>å‘ç°å¹¶åˆ©ç”¨å…‰åˆç»†èŒå¸æ”¶é™è§£æŒä¹…æ€§æœ‰æœºæ±¡æŸ“ç‰©ï¼ˆPFASï¼‰çš„èƒ½åŠ›ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ“° å…¬ä¼—å· (38æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>æœ€æ–°14+ç”Ÿä¿¡ï¼Œé€šè¿‡å•ç»†èƒåˆ†æè¯†åˆ«HLA-DR +è‚¿ç˜¤ç»†èƒï¼Œå¹¶åˆ†æå…¶å¯¹ CD8+T ç»†èƒåŠé¢„åçš„å½±å“ï¼Œæ€è·¯æ–°é¢–ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€Tç»†èƒã€å•ç»†èƒã€ç”Ÿä¿¡ã€é€šè·¯</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504099&amp;idx=4&amp;sn=05e843389ca7219100c46075fdfa69b0">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>æœ€æ–°14+çƒ­ç‚¹å¥½æ–‡ï¼Œå·¨å™¬ç»†èƒèƒè‘¬é©±åŠ¨å¤šèƒºä»£è°¢å¢å¼ºåŒ–ç–—åç™Œå¹²ç»†èƒå¯Œé›†åŠè€è¯ï¼ç”Ÿä¿¡å‘ç°ç°è±¡ï¼Œå®éªŒè§£é‡Šç°è±¡ï¼Œæ¢ç´¢æœºåˆ¶ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå·¨å™¬ç»†èƒã€ä»£è°¢ã€è€è¯ã€ç”Ÿä¿¡ã€å¯Œé›†</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504099&amp;idx=1&amp;sn=0d3ec16d44e3b9307b794f06ad777f59">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>è½¬å½•ç»„å­¦çš„ç”Ÿç‰©ä¿¡æ¯å­¦è§†è§’ï¼šæ‰¹é‡ä¸å•ç»†èƒ RNA æµ‹åºåˆ†æçš„å…¨é¢ç»¼è¿°</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šBMELab</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šæµ‹åºã€å•ç»†èƒã€è½¬å½•ç»„ã€ç”Ÿç‰©ä¿¡æ¯ã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šè½¬å½•ç»„å­¦çš„ç”Ÿç‰©ä¿¡æ¯å­¦è§†è§’ï¼šæ‰¹é‡ä¸å•ç»†èƒ RNA æµ‹åºåˆ†æçš„å…¨é¢ç»¼è¿°</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkyNDI1MzE0NA==&amp;mid=2247490208&amp;idx=1&amp;sn=9a13efc0a529369358475cedfc491af7">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>æœ€æ–°14+ç”Ÿä¿¡ï¼Œå•ç»†èƒè¯†åˆ«MARCO+å·¨å™¬ç»†èƒæŠ‘åˆ¶CD8Tï¼Œé˜»æ–­MARCOå¢å¼ºå…ç–«æ²»ç–—ç–—æ•ˆã€‚å¹²æ¹¿ç»“åˆç»å…¸é«˜åˆ†æ€è·¯ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€å·¨å™¬ç»†èƒã€å•ç»†èƒã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504099&amp;idx=7&amp;sn=b3adb73de6de34506a3ace4ee2f920b7">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>æœ€æ–°14+ç”Ÿä¿¡ï¼Œå•ç»†èƒè¯†åˆ«PLAUR+ä¸­æ€§ç²’ç»†èƒå¡‘é€ å…ç–«æŠ‘åˆ¶å¾®ç¯å¢ƒï¼ŒæŠ‘åˆ¶PLAUR å¢å¼ºæŠ— PD1 ç–—æ•ˆã€‚é«˜åˆ†æ–‡ç« ç»å…¸æ€è·¯ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€å…ç–«å¾®ç¯å¢ƒã€å•ç»†èƒã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504099&amp;idx=5&amp;sn=160e8f43fe8632ef5170207d01963382">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>Redox BiologyåŒåŒºTOPï¼å·¨å™¬ç»†èƒÃ—è¡°è€Ã—èƒè‘¬ä½œç”¨çš„æ–°æœºåˆ¶ï¼Œå€¼å¾—ä¸€å­¦</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šåŒåŒ»æµäº‘Medfocus</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè¡°è€ã€Tç»†èƒã€Bç»†èƒã€å·¨å™¬ç»†èƒ</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šå—é€šå¤§å­¦å´”å¿—æ˜/é’±æ¹›ç‘’å›¢é˜Ÿè¿‘æœŸåœ¨ã€ŠRedox Biologyã€‹å‘è¡¨ç ”ç©¶ï¼Œé¦–æ¬¡è¯å®ï¼šå·¨å™¬ç»†èƒå› è¿‡åº¦åå™¬é«“é˜ç¢ç‰‡è€Œæå‰è¡°è€ï¼Œæ˜¯è„Šé«“æŸä¼¤åä¿®å¤å—é˜»çš„å…³é”®ã€‚</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzk3NTY2NDk1Nw==&amp;mid=2247488360&amp;idx=3&amp;sn=8b9207bc1fcd68b884807cf008571108">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> â­ <strong>æœ€æ–°14+å¹²æ¹¿ç»“åˆSCIï¼Œä½œè€…é‰´å®šå‡ºå¹²æ‰°ç´ è¯±å¯¼çš„è¡°è€ CD8T ç»†èƒå¹¶æ­ç¤ºå…¶å¯¹å…ç–«æ²»ç–—çš„å½±å“ã€‚è¡°è€è™½è€ï¼Œä½†æ˜¯çœŸçš„ç«ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€è¡°è€ã€Tç»†èƒ</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504099&amp;idx=2&amp;sn=74a9955631053ddce413cf973c99d9e5">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> â­ <strong>DMFé‡Šæ”¾mtDNAï¼Œæ¿€æ´»cGAS-STINGé€šè·¯å¢å¼ºæŠ—è‚¿ç˜¤å…ç–«</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šåŒåŒ»æµäº‘Medfocus</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«ã€é€šè·¯</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šæ­ç¤ºâ€œçº¿ç²’ä½“-cGAS-STINGâ€è½´åœ¨DMFæŠ—è‚¿ç˜¤å…ç–«ä¸­çš„æ ¸å¿ƒåœ°ä½ã€‚</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzk3NTY2NDk1Nw==&amp;mid=2247488360&amp;idx=1&amp;sn=57a879d6fd063e10ae75b53ef6392601">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> â­ <strong>é‡ç£…ç ”ç©¶ï¼é¦–æ¬¡ç³»ç»Ÿæ­ç¤ºä¸‰çº§æ·‹å·´ç»“æ„åœ¨èƒƒç™Œå…ç–«å¾®ç¯å¢ƒä¸­çš„å…³é”®ä½œç”¨ï¼Œå¼€å‘åˆ›æ–°å·¥å…·ç²¾å‡†é¢„æµ‹å…ç–«æ²»ç–—ååº”</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šè½¬åŒ–åŒ»å­¦ç½‘</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€å…ç–«å¾®ç¯å¢ƒã€æ·‹å·´</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šé€šè¿‡å•ç»†èƒå’Œç©ºé—´è½¬å½•ç»„æŠ€æœ¯ï¼Œé¦–æ¬¡ç³»ç»Ÿæ­ç¤ºäº†ä¸‰çº§æ·‹å·´ç»“æ„åœ¨èƒƒç™Œå…ç–«å¾®ç¯å¢ƒä¸­çš„å…³é”®ä½œç”¨ã€‚</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656511096&amp;idx=1&amp;sn=6098ecb0a0264b1819b6e7a325955ea8">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> â­ <strong>ã€è½¬åŒ–åŒ»å­¦ç ”ç©¶ä¸“åœºã€‘å•ç»†èƒæµ‹åºå…¥é—¨å¤§è®²å ‚ï¼šåŠ©æ‚¨é”å®šæ–°é¶ç‚¹ã€ç ´è§£è€è¯æ€§ã€æ­ç¤ºæ¯’æ€§æœºåˆ¶ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼š10x Genomics</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè€è¯ã€æµ‹åºã€å•ç»†èƒ</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç›´æ’­æ—¶é—´ï¼š12æœˆ10æ—¥&amp;11æ—¥ï½œä¸‹åˆ 2:00-3:00</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzU1MDk1NTY5MA==&amp;mid=2247541029&amp;idx=1&amp;sn=b6f996f0168f755954193d7a79909504">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 28 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E5%85%AC%E4%BC%97%E5%8F%B7>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (44æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡-1>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE275681 MHC II é™åˆ¶æ€§æ–°æŠ—åŸç–«è‹—é€†è½¬å…ç–«å¾®ç¯å¢ƒå¹¶å…‹æœå†·è‚¿ç˜¤å¯¹å…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚çš„è€è¯æ€§ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€vaccineã€MHCã€resistance</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThis SuperSeries is composed of the SubSeries listed below.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275681">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE282415 é¤åå…¨èº«ä»£è°¢å˜åŒ–å¯¹ T ç»†èƒå…ç–«äº§ç”ŸæŒä¹…å½±å“ [ATAC-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€T cellã€metabolismã€ATAC-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Alok Kumar ; Greg M Delgoffe ; Isha MehtaSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusSystemic nutrient availability waxes and wanes with dietary input. Here we show that short periods of fasting and refeeding have long-lasting effects on T cell immunity. Human or murine T cells from fed hosts have higher metabolic capacity than those from fasted hosts ex vivo and show better/superior metabolic phenotype and immune response/functions in vitro and in vivo settings of virus infection or tumor model. Serum or chylomicrons enriched from lymphatics of fed mice restores the metabolic and immune functions of fasted T cells. Fed T cells had heightened mTORC1-dependent translation of key immunologic and metabolic genes independent of their epigenetic and transcriptional status. mTORC1 inhibition during the fed period mitigates the postprandial benefit of fed T cells over fasted cells. Our data highlight the need to consider diet content and timing as key factors in immune cell analysis, vaccination strategies, and the generation of cellular therapies.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282415">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE282410 é¤åå…¨èº«ä»£è°¢å˜åŒ–å¯¹ T ç»†èƒå…ç–«äº§ç”ŸæŒä¹…å½±å“ [RNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€T cellã€metabolismã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Alok Kumar ; Greg M Delgoffe ; Isha MehtaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusSystemic nutrient availability waxes and wanes with dietary input. Here we show that short periods of fasting and refeeding have long-lasting effects on T cell immunity. Human or murine T cells from fed hosts have higher metabolic capacity than those from fasted hosts ex vivo and show better/superior metabolic phenotype and immune response/functions in vitro and in vivo settings of virus infection or tumor model. Serum or chylomicrons enriched from lymphatics of fed mice restores the metabolic and immune functions of fasted T cells. Fed T cells had heightened mTORC1-dependent translation of key immunologic and metabolic genes independent of their epigenetic and transcriptional status. mTORC1 inhibition during the fed period mitigates the postprandial benefit of fed T cells over fasted cells. Our data highlight the need to consider diet content and timing as key factors in immune cell analysis, vaccination strategies, and the generation of cellular therapies.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282410">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE254001 NFATc1 å’Œ NFATc2 é€šè¿‡è°ƒèŠ‚èƒ†å›ºé†‡ç”Ÿç‰©åˆæˆå’Œ WNT/Î²-catenin é€šè·¯æ§åˆ¶å„¿ç«¥ T ç»†èƒæ€¥æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…ä¸­çš„ç³–çš®è´¨æ¿€ç´ æŠµæŠ—</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€resistanceã€pathway</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by arrayOrganism : Homo sapiensThis SuperSeries is composed of the SubSeries listed below.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE254001">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE253999 NFATc1 å’Œ NFATc2 é€šè¿‡è°ƒèŠ‚èƒ†å›ºé†‡ç”Ÿç‰©åˆæˆå’Œ WNT/Î²-catenin é€šè·¯æ¥è°ƒæ§å„¿ç«¥ T ç»†èƒæ€¥æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…ä¸­çš„ç³–çš®è´¨æ¿€ç´ æŠµæŠ—</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€resistanceã€pathway</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Silvia Bresolin ; Valentina SerafinSeries Type : Expression profiling by arrayOrganism : Homo sapienshe glucocorticoid (GC) resistance onset in pediatric T-cell Acute Lymphoblastic Leukemia (T-ALL) patients remains one of the biggest challenges in current cancer treatment. The mechanisms driving this resistance are still not fully understood, making it difficult to predict patient outcomes and to develop effective therapies. Our study uncovered critical insights into the biological processes underlying GC resistance, offering potential breakthroughs for future treatments. Building on our previous research on LCK kinase hyperactivation in GC-resistant T-ALL patients, we have now delved deeper into the LCK downstream NFAT transcription factor family&rsquo;s contribution to GC resistance. We discovered that, even at the time of diagnosis, GC resistant T-ALL patients exhibit an intrinsic low glucocorticoid receptor (GR) activity coupled with high NFATc1 and NFATc2 ones. This dysregulation creates a roadblock to effective GC therapy. Indeed, in the absence of either NFATc1 or NFATc2, the normal transcriptional activity of GR is restored, re-sensitizing the leukemia cells to dexamethasone treatment both in vitro and in vivo. This suggests that NFATc1 and NFATc2 are central to driving GC resistance, as they directly regulate crucial pathways like cholesterol biosynthesis and WNT/Î²-catenin signaling. The identification of NFAT transcription factors as key players in leukemia therapy resistance offers a promising target for future therapeutic strategies, potentially transforming the way we approach treatment for these challenging conditions or autoimmune disorders where glucocorticoids are a cornerstone of treatment.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253999">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE253998 NFATc1 å’Œ NFATc2 é€šè¿‡è°ƒèŠ‚èƒ†å›ºé†‡ç”Ÿç‰©åˆæˆå’Œ WNT/Î²-catenin é€šè·¯æ¥è°ƒæ§å„¿ç«¥ T ç»†èƒæ€¥æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…ä¸­çš„ç³–çš®è´¨æ¿€ç´ æŠµæŠ—</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€resistanceã€pathway</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Silvia Bresolin ; Valentina SerafinSeries Type : Expression profiling by arrayOrganism : Homo sapiensThe glucocorticoid (GC) resistance onset in pediatric T-cell Acute Lymphoblastic Leukemia (T-ALL) patients remains one of the biggest challenges in current cancer treatment. The mechanisms driving this resistance are still not fully understood, making it difficult to predict patient outcomes and to develop effective therapies. Our study uncovered critical insights into the biological processes underlying GC resistance, offering potential breakthroughs for future treatments. Building on our previous research on LCK kinase hyperactivation in GC-resistant T-ALL patients, we have now delved deeper into the LCK downstream NFAT transcription factor family&rsquo;s contribution to GC resistance. We discovered that, even at the time of diagnosis, GC resistant T-ALL patients exhibit an intrinsic low glucocorticoid receptor (GR) activity coupled with high NFATc1 and NFATc2 ones. This dysregulation creates a roadblock to effective GC therapy. Indeed, in the absence of either NFATc1 or NFATc2, the normal transcriptional activity of GR is restored, re-sensitizing the leukemia cells to dexamethasone treatment both in vitro and in vivo. This suggests that NFATc1 and NFATc2 are central to driving GC resistance, as they directly regulate crucial pathways like cholesterol biosynthesis and WNT/Î²-catenin signaling. The identification of NFAT transcription factors as key players in leukemia therapy resistance offers a promising target for future therapeutic strategies, potentially transforming the way we approach treatment for these challenging conditions or autoimmune disorders where glucocorticoids are a cornerstone of treatment.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253998">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> â­ <strong>GSE253996 ç ”ç©¶å‘ç°ï¼ŒNFATc1 å’Œ NFATc2 é€šè¿‡è°ƒèŠ‚èƒ†å›ºé†‡ç”Ÿç‰©åˆæˆå’Œ WNT/Î²-catenin é€šè·¯æ¥è°ƒæ§å„¿ç«¥ T ç»†èƒæ€¥æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…ä¸­çš„ç³–çš®è´¨æ¿€ç´ æŠµæŠ—ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€resistanceã€pathway</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Silvia Bresolin ; Valentina SerafinSeries Type : Expression profiling by arrayOrganism : Homo sapiensThe glucocorticoid (GC) resistance onset in pediatric T-cell Acute Lymphoblastic Leukemia (T-ALL) patients remains one of the biggest challenges in current cancer treatment. The mechanisms driving this resistance are still not fully understood, making it difficult to predict patient outcomes and to develop effective therapies. Our study uncovered critical insights into the biological processes underlying GC resistance, offering potential breakthroughs for future treatments. Building on our previous research on LCK kinase hyperactivation in GC-resistant T-ALL patients, we have now delved deeper into the LCK downstream NFAT transcription factor family&rsquo;s contribution to GC resistance. We discovered that, even at the time of diagnosis, GC resistant T-ALL patients exhibit an intrinsic low glucocorticoid receptor (GR) activity coupled with high NFATc1 and NFATc2 ones. This dysregulation creates a roadblock to effective GC therapy. Indeed, in the absence of either NFATc1 or NFATc2, the normal transcriptional activity of GR is restored, re-sensitizing the leukemia cells to dexamethasone treatment both in vitro and in vivo. This suggests that NFATc1 and NFATc2 are central to driving GC resistance, as they directly regulate crucial pathways like cholesterol biosynthesis and WNT/Î²-catenin signaling. The identification of NFAT transcription factors as key players in leukemia therapy resistance offers a promising target for future therapeutic strategies, potentially transforming the way we approach treatment for these challenging conditions or autoimmune disorders where glucocorticoids are a cornerstone of treatment.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253996">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>GSE287189ï¼šå¹´è½»å’Œå¹´è€å¡è±é»‘ç¾Šåµå·¢ä¸­m6Aç”²åŸºåŒ–å’Œè½¬å½•ç»„è°±å·®å¼‚çš„ç»¼åˆåˆ†æ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štranscriptomeã€methylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Linlin Pei ; Chunjie LiuSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Ovis ariesOvarian aging results in follicular failure and atresia, leading to a decline in both the quantity and quality of oocytes. N6-methyladenosine (m6A) has been demonstrated to play a regulatory role in the reproductive functions of female animals; however, the regulatory mechanisms of m6A in the ovaries of sheep remain unclear. In the present study, ovarian tissues from 1~2 year-old and 5~6 year-old Cele black sheep were collected and analyzed using MeRIP-seq and RNA-seq sequencing. A total of 109 differentially methylated genes were identified, including 7 genes that were up-regulated in both methylation and mRNA expression, 55 genes that were up-regulated in methylation while down-regulated in mRNA expression, and 33 genes that were down-regulated in both methylation and mRNA expression. Additionally, 14 genes exhibited down-regulation in methylation and up-regulation in mRNA expression. Differential methylation peaks (DMPs) were found to be significantly enriched in the BMP signaling pathway, uterine embryonic development, histone acetyltransferase activity, and VEGF signaling pathway by GO and KEGG enrichment analysis. Differentially expressed genes (DEGs) were significantly enriched in negative regulation of the I-kappaB kinase/NF-kappaB signalling pathway, positive regulation of leukocyte adhesion to vascular endothelial cells, histone methyltransferase binding, transcriptional co-repressor activity, and cellular senescence. The results suggest that differentially expressed genes may influence various biological functions, including transcription, translation, aging, development, regeneration, and immune responses in the ovary of sheep. In this study, we constructed the first comprehensive whole transcriptome analysis map of the sheep ovary, which provides a theoretical foundation for investigating the transcriptional regulation mechanisms of m6A modification in the ovary.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287189">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>GSE272644 BRCA1 çªå˜å’Œè¡¨è§‚çªå˜æºå¸¦è€…çš„è¡€ç»†èƒå…¨åŸºå› ç»„ç”²åŸºåŒ–è°±ã€ä¹³è…ºç™Œè¯Šæ–­å‰æ—¢æ—  BRCA1 çªå˜ä¹Ÿæ— è¡¨è§‚çªå˜çš„å¥³æ€§ä»¥åŠæ—¢æ—  BRCA1 çªå˜ä¹Ÿæ— è¡¨è§‚çªå˜çš„å¥åº·å¥³æ€§ï¼ˆå¯¹ç…§ç»„ï¼‰</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgenomeã€methylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Katarzyna E Sokolowska ; Jacek Antoniewski ; Marta Sobalska-Kwapis ; Dominik Strapagiel ; Jan LubiÅ„ski ; Tomasz Huzarski ; Tomasz K WojdaczSeries Type : Methylation profiling by genome tiling arrayOrganism : Homo sapiensGenome-wide DNA methylation patterns were quantified in peripheral blood samples collected from 112 individuals (with determined BRCA1 mutation and epimutation status) using the Illumina Infinium HumanMethylationEPIC BeadChip</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272644">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>GSE272599 ä½¿ç”¨TIGERå¯¹Recql4 -/- Klhdc3 -/- ä¸å¯¹ç…§ç»„è¿›è¡Œå…¨åŸºå› ç»„æµ‹åºï¼ˆä¸‰é‡å¤ï¼‰ï¼Œåˆ†æå…¶å¤åˆ¶æ—¶é—´ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€genome</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : M F Smeets ; P A Buco ; A Koren ; A M Chalk ; C R WalkleySeries Type : OtherOrganism : Mus musculusAbstract TBC</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272599">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 34 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ”¬ æœŸåˆŠæ–‡ç«  (2æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨2æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰</h4><p><strong>1.</strong> <strong>æ™šæœŸå®«é¢ˆç™Œä¸­ï¼Œä¸€çº¿é™çº§åŒ–ç–—åŠ å½­æ™®åˆ©å•æŠ—å’Œå®‰æ´›æ›¿å°¼ååº”çš„åˆ†å­å’Œå…ç–«ç›¸å…³æ€§</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: æ™šæœŸå®«é¢ˆç™Œçš„æ ‡å‡†æŠ¤ç†åŒ…æ‹¬åŒ–ç–—ã€æŠ—è¡€ç®¡ç”Ÿæˆå’Œ/æˆ–å…ç–«æ£€æŸ¥ç‚¹é˜»æ»æ–¹æ¡ˆã€‚è™½ç„¶æœ‰æ•ˆï¼Œä½†ä¼šå¯¼è‡´å¤šæ•ˆæ€§å‰¯ä½œç”¨ã€‚é™çº§åŒ–ç–—ç»“åˆå…ç–«é¶å‘ç–—æ³•å·²è¢«è¯æ˜åœ¨å…¶ä»–ç™Œç—‡ä¸­æœ‰æ•ˆä¸”æ¯’æ€§è¾ƒä½ã€‚æœ¬ç ”ç©¶ä¸­ï¼Œæˆ‘ä»¬è¿›è¡Œäº†ä¸€é¡¹å¤šä¸­å¿ƒã€å•è‡‚ã€äºŒæœŸä¸´åºŠç ”ç©¶ï¼Œé’ˆå¯¹ä¸€çº¿é™çº§é“‚ç±»åŒ–ç–—åŠ å®‰æ´›æ›¿å°¼å’Œå½­æ™®åˆ©å•æŠ—ï¼Œéšåä»…ç”¨å®‰æ´›æ›¿å°¼å’Œå½­æ™®åˆ©å•æŠ—ç»´æŒæ²»ç–—æ²»ç–—ï¼Œæ²»ç–— PD-L1 é˜³æ€§ã€æŒç»­æ€§ã€å¤å‘æˆ–è½¬ç§»æ€§å®«é¢ˆç™Œæ‚£è€…ã€‚åœ¨ 32 ä¾‹æœ‰æ•ˆæ€§è¯„ä¼°æ‚£è€…ä¸­ï¼Œ30 ä¾‹ï¼ˆ93.8%ï¼Œ95%ç½®ä¿¡åŒºé—´ï¼š79.2%è‡³ 99.2%ï¼‰è·å¾—ç ”ç©¶è€…ç¡®è®¤çš„å®¢è§‚ååº”ã€‚å•æ ¸ RNA æµ‹åºæš—ç¤ºè‚¿ç˜¤æµ¸æ¶¦ T ç»†èƒå’Œæ´»åŒ–ç”Ÿæ®–ä¸­å¿ƒ B ç»†èƒçš„è¶‹åŒ–æ€§å’Œå¢æ®–æ´»æ€§å¢å¼ºï¼Œé¢„ç¤ºç€æœ€ä½³æ²»ç–—ååº”ã€‚TLS ä¸è‚¿ç˜¤é¢ç§¯æ¯”è¾ƒé«˜çš„æ‚£è€…å­˜æ´»ç‡è¾ƒé«˜ã€‚æˆ‘ä»¬çš„å‘ç°ä¸ºä¸€çº¿é™çº§åŒ–ç–—åŠ å®‰æ´›æ›¿å°¼å’Œå½­æ™®åˆ©å•æŠ—åœ¨è½¬ç§»æ€§ã€æŒç»­æ€§æˆ–å¤å‘æ€§å®«é¢ˆç™Œæ‚£è€…ä¸­çš„å¯è¡Œæ€§å¥ å®šäº†åŸºç¡€ã€‚</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1994144241297764352/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>å¯¹ CICï¼š:D UX4 è‚‰ç˜¤çš„å»ºæ¨¡æ­ç¤ºäº†ç™ŒåŸºå› ä»‹å¯¼çš„ MHCI ä¾èµ–å…ç–«é€ƒè„±ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: CICï¼š:D UX4 è‚‰ç˜¤ï¼ˆCDSï¼‰æ˜¯ä¸€ç§é«˜åº¦ä¾µè¢­æ€§çš„æ¶æ€§è‚¿ç˜¤ï¼Œæ²»ç–—é€‰æ‹©æœ‰é™ã€‚æœ¬æ–‡ä»‹ç»äº†ä¸€ä¸ªå¯è¯±å¯¼å¤šè¥¿ç¯ç´ çš„ CICï¼š:D UX4 åµŒåˆå°é¼ æ¨¡å‹åŠå…¶è¡ç”Ÿçš„ç™Œç—‡ç³» imChCDSï¼Œå¿ å®åœ°é‡ç°äº†äººç±» CDS çš„åˆ†å­ã€ç»„ç»‡å­¦å’Œå…ç–«å­¦ç‰¹å¾ã€‚æˆ‘ä»¬è¯æ˜ä»… CICï¼š:D UX4 è¡¨è¾¾å°±è¶³ä»¥é©±åŠ¨è½¯ç»“ç¼”ç»„ç»‡å…è®¸è°±ç³»çš„è‚¿ç˜¤å‘ç”Ÿã€‚imChCDS ç»†èƒç³»ä¿ç•™äº†å…¶é—´å……è´¨ç»†èƒèµ·æºçš„è½¬å½•è¶³è¿¹ï¼Œåœ¨å…ç–«åŠŸèƒ½æ­£å¸¸çš„å®¿ä¸»ä¸­å‘ç”Ÿè½¬ç§»æ€§è‚¿ç˜¤ï¼Œå¹¶æ˜æ˜¾ä¾èµ– P300/CBP è½¬å½•å…±æ¿€æ´»å› å­ã€‚å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œæˆ‘ä»¬å‘ç° CICï¼š:D UX4/P300/CBP ä»‹å¯¼çš„ MHC I ç±»ï¼ˆMHCIï¼‰æŠ‘åˆ¶æ˜¯ CDS å…ç–«é€ƒé¿çš„å…³é”®æœºåˆ¶ã€‚CICï¼š:D UX4 çš„é—ä¼ å¤±æ´»æˆ– P300/CBP çš„è¯ç‰©æŠ‘åˆ¶å¯è¯±å¯¼ç™Œç»†èƒå‘¨æœŸåœæ­¢ï¼Œæ¢å¤ MHCI è¡¨è¾¾ï¼Œå¹¶è§¦å‘å¼ºå¥çš„æŠ—è‚¿ç˜¤å…ç–«ååº”ï¼Œä»è€Œå°†å…ç–«å­¦ä¸Šâ€œå†·â€çš„ CDS å¾®ç¯å¢ƒè½¬å˜ä¸ºâ€œçƒ­â€ç¯å¢ƒï¼Œæ¨åŠ¨è‚¿ç˜¤é€€ç¼©ã€‚è¿™äº›æ¨¡å‹å…±</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1994175845021888512/t>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (4æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨4æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨4æ¡ï¼‰</h4><p><strong>1.</strong> <strong>ä¸€é¡¹å†æ—¶äºŒåå¹´çš„ç ”ç©¶è¡¨æ˜ï¼Œæ›´æ¸…æ´çš„æ°´èƒ½å¤§å¹…é™ä½ç™Œç—‡å’Œå¿ƒè„ç—…æ­»äº¡ç‡ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šA 20-year project in Bangladesh reveals that lowering arsenic levels in drinking water can slash death rates from major chronic diseases. Participants who switched to safer wells had the same risk levels as people who were never heavily exposed. The researchers tracked individual water exposure with detailed urine testing. Their results show how quickly health improves once contaminated water is replaced.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2025/11/251127010327.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>ä½ çš„èº«ä½“å¯èƒ½å·²ç»å­˜åœ¨ä¸€ç§æœ‰åŠ©äºå¯¹æŠ—é˜¿å°”èŒ¨æµ·é»˜ç—…çš„åˆ†å­ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šAlzheimer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSpermine, a small but powerful molecule in the body, helps neutralize harmful protein accumulations linked to Alzheimerâ€™s and Parkinsonâ€™s. It encourages these misfolded proteins to gather into manageable clumps that cells can more efficiently dispose of through autophagy. Experiments in nematodes show that spermine also enhances longevity and cellular energy production. These insights open the door to targeted therapies powered by polyamines and advanced AI-driven molecular design.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2025/11/251126095023.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>çº³ç±³èŠ±å¢å¼ºå¹²ç»†èƒæ´»åŠ›ï¼Œä»è€Œä¿®å¤è¡°è€ç»†èƒ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šaging</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šTexas A&amp;M researchers found a way to make stem cells produce double the normal number of mitochondria using nanoflower particles. These energized stem cells then transfer their surplus â€œpower packsâ€ to weakened cells, reviving their energy production and resilience. The method bypasses many limitations of current mitochondrial therapies and could offer long-lasting effects. It may open the door to treatments for aging tissues and multiple degenerative diseases.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2025/11/251126095020.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> <strong>è¿™ç§å¾®å°çš„å¾®ç”Ÿç‰©æˆ–è®¸æ˜¯æˆ˜èƒœæ°¸ä¹…æ€§åŒ–å­¦ç‰©è´¨çš„å…³é”®ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šregex:micro(b|be|bial|organism)</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šA photosynthetic bacterium shows a surprising ability to absorb persistent PFAS chemicals, offering a glimpse into biological tools that might one day tackle toxic contamination. Researchers are now exploring genetic and synthetic biology approaches to enhance these early signs of PFAS-handling potential.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2025/11/251125081938.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>å…ç–«</td><td>10</td></tr><tr><td>ç”Ÿä¿¡</td><td>9</td></tr><tr><td>è‚¿ç˜¤</td><td>7</td></tr><tr><td>å•ç»†èƒ</td><td>7</td></tr><tr><td>Tç»†èƒ</td><td>7</td></tr><tr><td>epigenetic</td><td>7</td></tr><tr><td>ä»£è°¢</td><td>5</td></tr><tr><td>genome</td><td>5</td></tr><tr><td>RNA-seq</td><td>5</td></tr><tr><td>immune</td><td>5</td></tr><tr><td>resistance</td><td>5</td></tr><tr><td>cancer</td><td>5</td></tr><tr><td>æµ‹åº</td><td>4</td></tr><tr><td>è¡°è€</td><td>4</td></tr><tr><td>è€è¯</td><td>4</td></tr><tr><td>ATAC-seq</td><td>4</td></tr><tr><td>leukemia</td><td>4</td></tr><tr><td>pathway</td><td>4</td></tr><tr><td>å·¨å™¬ç»†èƒ</td><td>3</td></tr><tr><td>sequencing</td><td>3</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-å…¬ä¼—å·></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (28æ¡)</summary><div class=details-content markdown=1><ul><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&amp;mid=2247503148&amp;idx=2&amp;sn=1fd522a4f521da4c2d9cc0939cfcc9d2">è‚¿ç˜¤å…ç–« | TrendsCancer | è›‹ç™½é…¶å¯¹è‚¿ç˜¤-å…ç–«ç»†èƒå…±ç”Ÿå…³ç³»çš„è°ƒæ§</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&amp;mid=2247503148&amp;idx=1&amp;sn=be44ba4e48cf8e1bf1560c82e222b946">åŸºå› ç»„ | Nature | é€šè¿‡ä½“ç»†èƒè¡¨çªå˜çš„å…‹éš†è¿½è¸ªæ­ç¤ºè¡€æ¶²è¡°è€çš„åŠ¨æ€å˜åŒ–</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2OTU2MzM2NA==&amp;mid=2247493048&amp;idx=1&amp;sn=23ee503b89c7c9e5d07510a46b3cda5a">æœ€æ–°Cancer Cellé‡ç£…ï¼Œèƒ°è…ºç™Œä¸­é¦–æ¬¡è¯å®ç¥ç»å…ƒä¸ç™Œç»†èƒé—´å­˜åœ¨ â€œç¥ç»å…ƒ-ç™Œç»†èƒå‡æ€§çªè§¦â€ï¼Œå¹¶å½¢æˆæ­£åé¦ˆå¢å¼ºè‚¿ç˜¤ç¥ç»æµ¸æ¶¦ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzUzMTEwODk0Ng==&amp;mid=2247538298&amp;idx=1&amp;sn=59bd299693570cbcb39fd84948671b12">PDXå°é¼ DNAæµ‹åºæ¯”å¯¹åˆ°äººç±»æˆ–è€…å°é¼ å‚è€ƒåŸºå› ç»„ï¼ˆä½ ä»¥ä¸ºçš„æ¯”å¯¹å¹¶ä¸æ˜¯çœŸæ­£çš„æ¯”å¯¹ï¼‰</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzI4ODc5MDI5NA==&amp;mid=2247503612&amp;idx=1&amp;sn=7cefeafa15508d5f783ef97effbe6a3c">ã€Šè‡ªç„¶ã€‹ï¼šæ•™ç§‘ä¹¦åˆå¾—æ”¹äº†ï¼ç§‘å­¦å®¶é¦–æ¬¡å‘ç°ï¼ŒæŠ‘åˆ¶Tç»†èƒæŠ—ç™Œæ´»æ€§çš„PD-1ï¼Œç«Ÿç„¶è¿˜æ˜¯Tç»†èƒçš„ä¿æŠ¤ä¼ï¼Œå¯ä»¥é˜²æ­¢æ·‹å·´ç»“å†…Tç»†èƒè€—ç«­æˆ–æ­»äº¡</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247507736&amp;idx=1&amp;sn=df2b3e3cf7abe1c367c6ebfe671dc1a5">Cell Res | æ—åœ£å½©ç­‰å›¢é˜Ÿå‘ç°é€šè¿‡ä»£è°¢è°ƒæ§æ¥è°ƒåŠ¨ä½“å†…å›ºæœ‰å…ç–«åŠ›ï¼Œä½¿è‚ç™Œå°é¼ å®ç°å¯¿ç»ˆæ­£å¯â€”â€”â€œä»£è°¢æ€§å…ç–«æ²»ç–—â€</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248980&amp;idx=1&amp;sn=cd297931054a03df2da9e86bee1aee2e">Scienceç ´é¢˜ï¼šè¿™ä¸€åˆ†å­å†³å®šè‚¿ç˜¤å…ç–«èƒ½å¦çœŸæ­£è¢«æ¿€æ´»</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247659599&amp;idx=1&amp;sn=ed4923d85bb6214c8b5378f34d9d68d6">æˆ´ç£Šå›¢é˜ŸCHOMï¼šåŸºäºè›‹ç™½ç»“æ„æ£€ç´¢çš„äººä½“è‚ é“å¾®ç”Ÿç‰©ç»„åŠŸèƒ½ç ”ç©¶æ–°èŒƒå¼ | Cell Presså¯¹è¯ç§‘å­¦å®¶</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821476&amp;idx=2&amp;sn=a7390fff7939786b75f4bb83dc6b429e">å½“å¯¼å¸ˆåªç»™æˆ‘ä¸€ä¸ªå•ç»†èƒæµ‹åºæ•°æ®ï¼Œæˆ‘æ˜¯æ€ä¹ˆè®¾è®¡4ä¸ªè¯¾é¢˜çš„1â€”â€”å¦‚ä½•æŒ‘é€‰ç»†èƒç¾¤</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247534012&amp;idx=1&amp;sn=3234de029a12bd2eac1c4a275b5938a3">è¯è¿›ä¸ƒ | ä»å°ç”¨Windowsï¼Œç»ˆäºå¼€å§‹åšç”Ÿä¿¡</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzYyNDMwNjg3Nw==&amp;mid=2247484121&amp;idx=1&amp;sn=cada5367af04b24fdd5c40c77caaeb9e">ä¹™é†‡é…¸ä»£è°¢é€”å¾„ï¼ˆå»ºè®®æ”¶è—ï¼‰</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5MDk3Mzg4OA==&amp;mid=2247498522&amp;idx=1&amp;sn=b10488729a588f8e6f7a535533277b31">è¿˜åœ¨è‹¦è‹¦æ¯”å¯¹å¾®ç”Ÿç‰©åºåˆ—ï¼ŸKraken2è½»æ¾å®ç°è¶…å¿«é€Ÿçš„å¾®ç”Ÿç‰©ç»„åˆ†ç±»ï¼Œæ•°æ®å¤„ç†æ•ˆç‡ç¿»å€ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504099&amp;idx=6&amp;sn=f4c9c7c27a1f866556e5882bff5487d9">å‘è¡¨åœ¨14.3åˆ†1åŒºï¼ˆAdvanced Scienceï¼‰çš„å¹²æ¹¿ç»“åˆæ–‡ç« ï¼Œèšç„¦åœ¨æˆçº¤ç»´ç»†èƒçš„è¡°è€è¡¨å‹ï¼Œå€¼å¾—å­¦ä¹ æ”¶è—ï¼Œå¯é‡å¤ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504099&amp;idx=3&amp;sn=4051b2330fdacd9461926cc7fb936397">åˆšåˆšå‘è¡¨çš„14+ç”Ÿä¿¡åˆ†æï¼Œè¯†åˆ«MMP11+æˆçº¤ç»´ç»†èƒè¿›è¡Œåˆ†æå’ŒéªŒè¯ï¼Œæœ¬æ–‡æ€è·¯æ–°é¢–ï¼Œå€¼å¾—è®¤çœŸå­¦ä¹ æ¨¡ä»¿ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247569258&amp;idx=2&amp;sn=2ba1887999f9f5d8eb07846d8317268f">ä»â€œæ— è¯å¯æ²»â€åˆ°â€œæœ‰è¯å¯åŒ»â€åŠæ•°åæ¬¾æ–°è¯åœ¨ç ”ï¼Œè¿™ç±»ç™Œç—‡æ‚£è€…è¿æ–°æ›™å…‰ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247569258&amp;idx=1&amp;sn=5a38565b32a19ac9aefbbec594226640">ã€Šè‡ªç„¶ã€‹é‡ç£…ï¼šç ´è§£ç»“ç›´è‚ ç™Œè€è¯ä¹‹è°œï¼æ–°ä¸€ä»£æ²»ç–—æ–¹å‘å·²å‡ºç°</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247547242&amp;idx=1&amp;sn=998166214fd574f2e22a9fda394de620">scATAC-seqåˆ†æï¼šå¦‚ä½•ä½¿ç”¨ bam åˆ›å»ºArrowæ–‡ä»¶ï¼Ÿ</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2MTExNTkwNA==&amp;mid=2247573862&amp;idx=1&amp;sn=2b98e046fb777713fcaa65a2a39fafd7">ç«‹æ„é«˜è¿œï¼è¿™ç¯‡Nature Canceræªå‡ºäº†è‚ç™Œç™Œå‰ç»†èƒçš„å…³é”®é¶ç‚¹ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248980&amp;idx=7&amp;sn=043be78cbaf4346fee0bd188add122f4">67åˆ†å·¨ä½œï¼Œå¸¦ä½ ç”¨çˆ†ç«çš„ä»£è°¢é‡ç¼–ç¨‹å®ç°å¼¯é“è¶…è½¦</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248980&amp;idx=6&amp;sn=aa07cacc08c353b5a8129e7ac883519e">Cell Genomæœ€æ–°åŠ›ä½œï¼å¤šç»„å­¦+å­Ÿå¾·å°”éšæœºåŒ–åˆ†æï¼Œç ´è§£è¡€æ¸…ä»£è°¢ç‰©ä¸æ…¢æ€§ç–¾ç—…çš„é—ä¼ å…³è”ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248980&amp;idx=5&amp;sn=41622cb46ce43273bad0096b7c36c932">28 æ ·æœ¬ IF40.4ï¼è§£å¯†ç‹çº¢é˜³é™¢å£«å›¢é˜Ÿçš„å•ç»†èƒåˆ›æ–°å¯†ç </a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248980&amp;idx=3&amp;sn=c23aa42c89c94b35f9a21d3338eed481">æœ€æ–°27+ç”Ÿä¿¡ï¼ŒåŸæ¥åªåšäº†è¿™äº›æ“ä½œï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248980&amp;idx=2&amp;sn=88531863743ccd2990dbb14426750f92">é¢„åˆ¶èœæœ€åº”è¯¥å‡ºç°åœ¨ç”Ÿä¿¡é¢†åŸŸ</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247650903&amp;idx=5&amp;sn=e9d1ca081df717f5c0acb5f04c4be751">PNASï¼šä¸­å±±å¤§å­¦ç‹å†›èˆ°å›¢é˜Ÿåœ¨å°ç»†èƒè‚ºç™ŒåŒ–ç–—è€è¯æ–°æœºåˆ¶åŠå¹²é¢„æ–°é¶ç‚¹ç ”ç©¶é¢†åŸŸå–å¾—è¿›å±•</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247650903&amp;idx=1&amp;sn=ffa679be1223d7152ce8074c16138087">è¿™ç§å¸¸è§ç»´ç”Ÿç´ ï¼Œç«Ÿæ˜¯æŠ—è‚¿ç˜¤é¶ç‚¹ï¼æ¸…åå¤§å­¦å›¢é˜Ÿå‘ç°ï¼šé€šè¿‡è†³é£Ÿè·å–å³å¯ä¿ƒè¿›è‚¿ç˜¤æ¸…é™¤èƒ½åŠ›</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkwMzY2NjkwNg==&amp;mid=2247495770&amp;idx=1&amp;sn=95c60c376c5d08a7ee6f4b7b4a2906fd">Natureå­åˆŠ |æ™ºèƒ½ç©ºé—´ç»„å­¦æŠ€æœ¯ S2-omic |è¯»è¿™ç¯‡æ–‡ç« èƒ½æŠŠç©ºé—´ç»„å­¦ç°çŠ¶ã€åº”ç”¨å’Œæ•°æ®åˆ†æå­¦æ˜ç™½</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656511096&amp;idx=4&amp;sn=4433f4b8ae80caa09264fc6b5753cd49">å¯é¢„æµ‹ICI-åŒ–ç–—æ²»ç–—æ•ˆæœï¼ä¸­å›½åŒ»å­¦ç§‘å­¦é™¢è‚¿ç˜¤åŒ»é™¢ç­‰å•ä½å‘æ–‡ï¼šæœ‰å‰æ™¯çš„è‚ºç™Œé¢„æµ‹ç”Ÿç‰©æ ‡å¿—ç‰©</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkxODY4NDEwMA==&amp;mid=2247490144&amp;idx=1&amp;sn=3418f002325fbfcf782ec096c24dcb34">é«˜æµ“åº¦å±€éƒ¨è¾£æ¤’ç´ æ²»ç–—ç³–å°¿ç—…å‘¨å›´ç¥ç»ç—…å˜:æœºåˆ¶ä¸ä¸´åºŠå‰æ™¯</a></li></ul></div></details><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (34æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306804">GSE306804 äº§åæ¯ä½“è¡€æ¶²ä¸­ç»†èŒçš„å¿«é€Ÿæ¸…é™¤ï¼Œé€‚ç”¨äºèƒè†œæ—©ç ´å¹¶å‘å¦Šå¨ çš„æƒ…å†µã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311151">GSE311151 è„‘ç™Œæ‚£è€…ä½“å†…ä»£è°¢é€šé‡ä¼°ç®—çš„æ•°å­—å­ªç”Ÿæ¨¡å‹</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310554">GSE310554 é…å¯¹è¡€ç®¡-å®è´¨å•æ ¸æµ‹åºæ­ç¤ºé˜¿å°”èŒ¨æµ·é»˜ç—…ä¸­å†…çš®-é—´è´¨è½¬åŒ–ç´Šä¹±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298006">GSE298006 é˜¶æ®µç‰¹å¼‚æ€§è¡¨è§‚é—ä¼ å¯åŠ¨åœ¨è°±ç³»å†³å®šè¿‡ç¨‹ä¸­å¢å¼ºåŸºå› æ¿€æ´» [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298001">GSE298001 é˜¶æ®µç‰¹å¼‚æ€§è¡¨è§‚é—ä¼ å¯åŠ¨åœ¨è°±ç³»å†³å®šè¿‡ç¨‹ä¸­å¢å¼ºåŸºå› æ¿€æ´» [ATAC-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295550">GSE295550 æŸ“è‰²è´¨å¯åŠæ€§å’ŒåŸºå› è¡¨è¾¾åŠ¨æ€è¡¨æ˜ç»´ç”Ÿç´  D3 åœ¨ä½“å†…å…·æœ‰å…ç–«è°ƒèŠ‚ä½œç”¨ [ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295549">GSE295549 æŸ“è‰²è´¨å¯åŠæ€§å’ŒåŸºå› è¡¨è¾¾åŠ¨æ€æ­ç¤ºç»´ç”Ÿç´  D3 åœ¨ä½“å†…çš„å…ç–«è°ƒèŠ‚ä½œç”¨ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286942">GSE286942 DOT1LæŠ‘åˆ¶å‰‚é€šè¿‡æ¿€æ´»ä¹³è…ºç™Œç»†èƒä¸­çš„å¹²æ‰°ç´ ä¿¡å·é€šè·¯å‘æŒ¥æŠ—è‚¿ç˜¤ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE235046">GSE235046 å…ˆå¤©å…ç–«å’Œä»£è°¢ä¿¡å·å°†å—æŸçº¿ç²’ä½“æ»ç•™åœ¨ç»†èƒè†œä¸Šä»¥è¿›è¡Œçº¿ç²’ä½“æ°§åŒ–æŸä¼¤</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221564">GSE221564 è‚¿ç˜¤ç»†èƒå†…åœ¨RIG-Iæ¿€æ´»è¶³ä»¥é©±åŠ¨å…ç–«ä»‹å¯¼çš„è‚¿ç˜¤æ’æ–¥</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302831">GSE302831 é€šè¿‡RNAæµ‹åºé‰´å®šé“¶å±‘ç—…ä¸­å·®å¼‚è¡¨è¾¾åŸºå› </a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292493">GSE292493 C-Cè¶‹åŒ–å› å­å—ä½“4çš„åŸºå› ç¼ºé™·å¯ä¿æŠ¤å°é¼ å…å—è¡€ç®¡ç´§å¼ ç´ IIè¯±å¯¼çš„è…¹ä¸»åŠ¨è„‰ç˜¤å½¢æˆ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291310">GSE291310 L-è‹¯ä¸™æ°¨é…¸å¯¹Th2ç»†èƒçš„ä»£è°¢è°ƒæ§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288012">GSE288012 å…¨åŸºå› ç»„ç­›é€‰é‰´å®šå‡º Runx2 æ˜¯é€ è¡€å¹²ç»†èƒæ‰©å¢å’Œ T ç»†èƒåˆ†åŒ–çš„æ–°å‹è°ƒæ§å› å­</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285478">GSE285478 å¤–æ³Œä½“ CLOCK ç¨³å®š lncRNA èµ‹äºˆç»“æ ¸ç—…æŠµæŠ—è€…å…ˆå¤©è®°å¿† [RNAseq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281009">GSE281009 é—´å……è´¨IL-33æ¿€æ´»ä¿®å¤æ€§å·¨å™¬ç»†èƒï¼Œä¿ƒè¿›è¡€ç®¡å†…æŸä¼¤è¯±å¯¼çš„æ–°å†…è†œå¢ç”Ÿ[scRNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281008">GSE281008 é—´å……è´¨IL-33æ¿€æ´»ä¿®å¤æ€§å·¨å™¬ç»†èƒï¼Œä¿ƒè¿›è¡€ç®¡å†…æŸä¼¤è¯±å¯¼çš„æ–°å†…è†œå¢ç”Ÿ[RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273174">GSE273174 åœ¨å…¨åŸºå› ç»„ CRISPR/Cas9 æ‹¯æ•‘ç­›é€‰ä¸­é‰´å®šä¸ Recql4 çš„æ–°å‹åŸºå› ç›¸äº’ä½œç”¨ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273006">GSE273006 åœ¨å…¨åŸºå› ç»„ CRISPR/Cas9 åˆæˆè‡´æ­»ç­›é€‰ä¸­é‰´å®šä¸ Recql4 çš„æ–°å‹åŸºå› ç›¸äº’ä½œç”¨ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311318">GSE311318 è½¯éª¨å¯¡èšåŸºè´¨è›‹ç™½ï¼ˆCOMPï¼‰åŸºå› ä¸é«˜çº§åˆ«è†€èƒ±ç™Œç›¸å…³å¹¶ä¿ƒè¿›è†€èƒ±ç™Œç»†èƒå¢æ®–</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311202">GSE311202 å¤§è‚ æ†èŒæ„ŸæŸ“æœŸé—´ä¸ Th17 ç»†èƒå…±åŸ¹å…»çš„å£è…”è§’è´¨å½¢æˆç»†èƒçš„è½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310377">GSE310377 èƒç›˜å¤–æ³Œä½“ miR-24-1-5p åœ¨ LPS è¯±å¯¼çš„ç‚ç—‡ä¸­çš„ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307410">GSE307410 è«å“ˆç»´èŠ½å­¢æ†èŒåç”Ÿå…ƒï¼šå¯¹ç»“è‚ ç™Œç»†èƒçš„è½¬å½•ç»„å­¦å’ŒæŠ—ç™Œä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298010">GSE298010 é˜¶æ®µç‰¹å¼‚æ€§è¡¨è§‚é—ä¼ å¯åŠ¨å¢å¼ºè°±ç³»å®šå‘è¿‡ç¨‹ä¸­çš„åŸºå› æ¿€æ´» [Micro-C]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298008">GSE298008 é˜¶æ®µç‰¹å¼‚æ€§è¡¨è§‚é—ä¼ å¯åŠ¨å¢å¼ºè°±ç³»å®šå‘è¿‡ç¨‹ä¸­çš„åŸºå› æ¿€æ´» [å¤šç»„]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298005">GSE298005 é˜¶æ®µç‰¹å¼‚æ€§è¡¨è§‚é—ä¼ å¯åŠ¨å¢å¼ºè°±ç³»å®šå‘è¿‡ç¨‹ä¸­çš„åŸºå› æ¿€æ´» [RELACS]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298002">GSE298002 é˜¶æ®µç‰¹å¼‚æ€§è¡¨è§‚é—ä¼ å¯åŠ¨å¢å¼ºè°±ç³»å®šå‘è¿‡ç¨‹ä¸­çš„åŸºå› æ¿€æ´» [CUT&amp;Run]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298000">GSE298000 é˜¶æ®µç‰¹å¼‚æ€§è¡¨è§‚é—ä¼ å¯åŠ¨åœ¨è°±ç³»å†³å®šè¿‡ç¨‹ä¸­å¢å¼ºåŸºå› æ¿€æ´» [4C]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291575">GSE291575 ä½“å¤–å¾ªç¯é€šè¿‡å‰ªåˆ‡åŠ›ä»‹å¯¼çš„é’™åº“æ“çºµæ€§å†…æµæ¿€æ´»ç»å…¸å•æ ¸ç»†èƒ [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279595">GSE279595 A-to-I RNA ç¼–è¾‘å¯é¢„é˜²è„‚è‚ªç»„ç»‡ä¸­ç‚ç—‡ä»‹å¯¼çš„è„‚è‚ªè¥å…»ä¸è‰¯</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221529">GSE221529 ç–¾ç—…ç›¸å…³çš„ p63 DBD çªå˜é€šè¿‡ä¸åŒçš„æœºåˆ¶å’Œä¸åŒç¨‹åº¦æŸå®³ DNA ç»“åˆ [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221525">GSE221525 ç–¾ç—…ç›¸å…³çš„ p63 DBD çªå˜é€šè¿‡ä¸åŒçš„æœºåˆ¶å’Œä¸åŒç¨‹åº¦æŸå®³ DNA ç»“åˆ [ChIP-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221520">GSE221520 ç–¾ç—…ç›¸å…³çš„ p63 DBD çªå˜é€šè¿‡ä¸åŒçš„æœºåˆ¶å’Œä¸åŒç¨‹åº¦æŸå®³ DNA ç»“åˆ [ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221088">GSE221088 åŸºäºå¾ªç¯å°ç»†èƒå¤–å›Šæ³¡çš„ miRNA åˆ†ç±»å™¨åœ¨æ»¤æ³¡æ€§ç”²çŠ¶è…ºç™Œè¯Šæ–­ä¸­çš„åº”ç”¨ï¼šä¸€é¡¹å¤šä¸­å¿ƒè¯Šæ–­ç ”ç©¶</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-28 21:33</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week482025/ rel=tag>Week482025</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2025-11-28/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-28</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2025-11-30/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-30</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-28/>ç§‘ç ”æ—¥æŠ¥ 2026-01-28</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-27/>ç§‘ç ”æ—¥æŠ¥ 2026-01-27</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-26/>ç§‘ç ”æ—¥æŠ¥ 2026-01-26</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-25/>ç§‘ç ”æ—¥æŠ¥ 2026-01-25</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-24/>ç§‘ç ”æ—¥æŠ¥ 2026-01-24</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (91)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (91)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>